VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q50765473  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241221010840.0
008     241221nneanz||abbn n and d
035 ‎‡a  (WKP)Q50765473‏
024 ‎‡a  0000-0002-9955-8746‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q50765473‏
100 0 ‎‡a  María Sala‏ ‎‡9  ast‏ ‎‡9  es‏ ‎‡9  sl‏
375 ‎‡a  2‏ ‎‡2  iso5218‏
400 0 ‎‡a  María Sala‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  María Sala‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's A death certificate-based study of occupation and mortality from reproductive cancers among women in 24 US states‏
670 ‎‡a  Author's A retrospective review of medical errors adjudicated in court between 2002 and 2012 in Spain‏
670 ‎‡a  Author's Actitudes de los trabajadores frente a los programas de promoción de la salud para la prevención del cáncer en el lugar del trabajo‏
670 ‎‡a  Author's Aggressiveness features and outcomes of true interval cancers: comparison between screen-detected and symptom-detected cancers.‏
670 ‎‡a  Author's Analysis of barriers and legal-ethical opportunities for disclosure and apology for medical errors in Spain‏
670 ‎‡a  Author's [Analysis of drug-related problems in a tertiary university hospital in Barcelona (Spain)]‏
670 ‎‡a  Author's Anxiety and depression in women with breast cancer: Social and clinical determinants and influence of the social network and social support (DAMA cohort)‏
670 ‎‡a  Author's Assessment of Feasibility of Workplace Health Promotion‏
670 ‎‡a  Author's Association between socioeconomic deprivation and colorectal cancer screening outcomes: Low uptake rates among the most and least deprived people.‏
670 ‎‡a  Author's Association between visual impairment and patient-reported visual disability at different stages of cataract surgery‏
670 ‎‡a  Author's Association of diabetes and diabetes treatment with incidence of breast cancer‏
670 ‎‡a  Author's Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case-control study‏
670 ‎‡a  Author's Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program.‏
670 ‎‡a  Author's Budget impact analysis of switching to digital mammography in a population-based breast cancer screening program: a discrete event simulation model‏
670 ‎‡a  Author's Can the Gail model increase the predictive value of a positive mammogram in a European population screening setting? Results from a Spanish cohort‏
670 ‎‡a  Author's Cancer mortality in workers exposed to organochlorine compounds in the pulp and paper industry: an international collaborative study‏
670 ‎‡a  Author's Cancer risk in the rubber industry: a review of the recent epidemiological evidence‏
670 ‎‡a  Author's [Changes in concentrations of organochloride compounds in women from Flix, Tarragona [Spain]].‏
670 ‎‡a  Author's Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program‏
670 ‎‡a  Author's Clinical and histologic characteristics of breast cancers in women with previous pathologic diagnosis of benign breast disease in Spain.‏
670 ‎‡a  Author's Clinical and radiological features of breast tumors according to history of false-positive results in mammography screening‏
670 ‎‡a  Author's Coffee consumption and bladder cancer in nonsmokers: a pooled analysis of case-control studies in European countries.‏
670 ‎‡a  Author's Correction to: Health care services use among long-term breast cancer survivors: a systematic review‏
670 ‎‡a  Author's Cost Attributable to Nosocomial Bacteremia. Analysis According to Microorganism and Antimicrobial Sensitivity in a University Hospital in Barcelona.‏
670 ‎‡a  Author's Cost-effectiveness of early detection of breast cancer in Catalonia (Spain).‏
670 ‎‡a  Author's Costes asociados a las bacteriemias nosocomiales en un hospital universitario‏
670 ‎‡a  Author's Cross-national comparison of screening mammography accuracy measures in U.S., Norway, and Spain.‏
670 ‎‡a  Author's Detection methods predict differences in biology and survival in breast cancer patients.‏
670 ‎‡a  Author's Does digital mammography suppose an advance in early diagnosis? Trends in performance indicators 6 years after digitalization‏
670 ‎‡a  Author's Economic impact of nosocomial bacteraemia. A comparison of three calculation methods‏
670 ‎‡a  Author's Effect of false-positives and women's characteristics on long-term adherence to breast cancer screening‏
670 ‎‡a  Author's Effect of information about the benefits and harms of mammography on women's decision making: The InforMa randomised controlled trial‏
670 ‎‡a  Author's Effect of participation on the cumulative risk of false-positive recall in a breast cancer screening programme.‏
670 ‎‡a  Author's Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections.‏
670 ‎‡a  Author's Eleven-year descriptive analysis of closed court verdicts on medical errors in Spain and Massachusetts.‏
670 ‎‡a  Author's Evaluation of hand hygiene adherence in a tertiary hospital‏
670 ‎‡a  Author's Evaluation of the interval cancer rate and its determinants on the Girona Health Region's early breast cancer detection program‏
670 ‎‡a  Author's Excretion of hexachlorobenzene and metabolites in feces in a highly exposed human population‏
670 ‎‡a  Author's Exploring the Role of Breast Density on Cancer Prognosis among Women Attending Population-Based Screening Programmes‏
670 ‎‡a  Author's Exposición a contaminantes atmosféricos durante el embarazo y desarrollo prenatal y neonatal: protocolo de investigación en el proyecto INMA‏
670 ‎‡a  Author's Exposición a contaminantes atmosféricos durante el embarazo y desarrollo prenatal y neonatal: protocolo de investigación en el proyecto INMA (Infancia y Medio Ambiente)‏
670 ‎‡a  Author's Exposure to asbestos and lung and pleural cancer mortality among pulp and paper industry workers‏
670 ‎‡a  Author's External validation of the PREDICT tool in Spanish women with breast cancer participating in population-based screening programmes‏
670 ‎‡a  Author's Factors that Influence Treatment Delay for Patients with Breast Cancer‏
670 ‎‡a  Author's Focus on hepatocellular carcinoma.‏
670 ‎‡a  Author's Gender-related differences in clinical and pathological characteristics and therapy of bladder cancer.‏
670 ‎‡a  Author's Gene expression profiling in true interval breast cancer reveals overactivation of the mTOR signaling pathway‏
670 ‎‡a  Author's Health care services use among long-term breast cancer survivors: a systematic review‏
670 ‎‡a  Author's Health effects of chronic high exposure to hexachlorobenzene in a general population sample‏
670 ‎‡a  Author's Health promotion trials at worksites and risk factors for cancer.‏
670 ‎‡a  Author's Impact of adjuvant chemotherapy on the survival of patients with breast cancer diagnosed by screening‏
670 ‎‡a  Author's Impact of comorbidity on survival by tumour location: Breast, colorectal and lung cancer (2000-2014).‏
670 ‎‡a  Author's [Impact of the distinct diagnostic criteria used in population-based studies on estimation of the prevalence of knee osteoarthritis]‏
670 ‎‡a  Author's Incremental cost of nosocomial bacteremia according to the focus of infection and antibiotic sensitivity of the causative microorganism in a university hospital.‏
670 ‎‡a  Author's Influence of Social Determinants, Lifestyle, Emotional Well-Being and the Use of Unconventional Therapies in Breast Cancer Progression in a Cohort of Women in Barcelona: Protocol for the DAMA Cohort.‏
670 ‎‡a  Author's Information to patient through an informed consent‏
670 ‎‡a  Author's Levels of hexachlorobenzene and other organochlorine compounds in cord blood: exposure across placenta.‏
670 ‎‡a  Author's Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.‏
670 ‎‡a  Author's Mammographic breast density: How it affects performance indicators in screening programmes?‏
670 ‎‡a  Author's Medida de contaminantes del agua y usos del agua durante el embarazo en un estudio de cohortes en España‏
670 ‎‡a  Author's Metabolism of hexachlorobenzene in humans: association between serum levels and urinary metabolites in a highly exposed population‏
670 ‎‡a  Author's Occupation and bladder cancer in a hospital-based case-control study in Spain.‏
670 ‎‡a  Author's Organochlorine compounds and concentrations of thyroid stimulating hormone in newborns.‏
670 ‎‡a  Author's Pesticides and congenital malformations--how many studies will it take to reach a conclusion?‏
670 ‎‡a  Author's Phenotypic characterization and risk factors for interval breast cancers in a population-based breast cancer screening program in Barcelona, Spain‏
670 ‎‡a  Author's Polychlorinated biphenyls (PCBs) and neurological development in children: a systematic review‏
670 ‎‡a  Author's Prácticas de cribado de cáncer y estilos de vida asociados en la población de controles del estudio español multi-caso control‏
670 ‎‡a  Author's Prácticas de cribado de cáncer y estilos de vida asociados en la población de controles del estudio español multi-caso control (MCC-Spain)‏
670 ‎‡a  Author's Prevalence of faecal incontinence and analysis of its impact on quality of life and mental health‏
670 ‎‡a  Author's Prevalence of fecal incontinence and its relationship with bowel habit in patients attended in primary care‏
670 ‎‡a  Author's Prevalence of persistent pain after breast cancer treatment by detection mode among participants in population-based screening programs‏
670 ‎‡a  Author's Readmissions and complications in breast ductal carcinoma in situ: A retrospective study comparing screen- and non-screen-detected patients‏
670 ‎‡a  Author's Reduction in false-positive results after introduction of digital mammography: analysis from four population-based breast cancer screening programs in Spain.‏
670 ‎‡a  Author's [Reflections on practices for early cancer diagnosis in Spain]‏
670 ‎‡a  Author's Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals‏
670 ‎‡a  Author's [Reply]‏
670 ‎‡a  Author's Results of a cervical cancer screening programme from an area of Barcelona‏
670 ‎‡a  Author's Results of a cervical cancer screening programme from an area of Barcelona (Spain) with a large immigrant population.‏
670 ‎‡a  Author's Risk excess of soft-tissue sarcoma and thyroid cancer in a community exposed to airborne organochlorinated compound mixtures with a high hexachlorobenzene content.‏
670 ‎‡a  Author's Risk factors for multidrug-resistant Pseudomonas aeruginosa acquisition. Impact of antibiotic use in a double case–control study‏
670 ‎‡a  Author's Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features.‏
670 ‎‡a  Author's Risk of hospital readmission and associated factors after a positive sample for a multidrug-resistant microorganism‏
670 ‎‡a  Author's Seroprevalence of Bartonella spp. infection in HIV patients in Catalonia, Spain.‏
670 ‎‡a  Author's Serum concentrations of hexachlorobenzene in family members of workers in an electrochemical factory.‏
670 ‎‡a  Author's Serum organochlorines and urinary porphyrin pattern in a population highly exposed to hexachlorobenzene‏
670 ‎‡a  Author's Seventeen-years overview of breast cancer inside and outside screening in Denmark‏
670 ‎‡a  Author's Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender‏
670 ‎‡a  Author's [Social and clinical determinants of the use of health services in women with breast cancer (Cohort DAMA)]‏
670 ‎‡a  Author's Social context for workplace health promotion: feasibility considerations in Costa Rica, Finland, Germany, Spain and Sweden‏
670 ‎‡a  Author's Survival and Disease-Free Survival by Breast Density and Phenotype in Interval Breast Cancers‏
670 ‎‡a  Author's The effect of information about the benefits and harms of mammography on women's decision-making: study protocol for a randomized controlled trial‏
670 ‎‡a  Author's The effect of smoking on prostate cancer survival: a cohort analysis in Barcelona‏
670 ‎‡a  Author's [The Environment and Childhood Research Network‏
670 ‎‡a  Author's The Environment and Childhood Research Network ("INMA" network): study protocol‏
670 ‎‡a  Author's Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study‏
670 ‎‡a  Author's Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10 years of follow-up.‏
670 ‎‡a  Author's Use of real-world data to study health services utilisation and comorbidities in long-term breast cancer survivors (the SURBCAN study): study protocol for a longitudinal population-based cohort study‏
670 ‎‡a  Author's Variability of breast surgery in women participating in breast cancer screening programs‏
670 ‎‡a  Author's প্রত্যুত্তর‏
909 ‎‡a  (orcid) 0000000299558746‏ ‎‡9  1‏
912 ‎‡a  পরতযততর‏ ‎‡A  প্রত্যুত্তর‏ ‎‡9  1‏
912 ‎‡a  reply‏ ‎‡A  [Reply]‏ ‎‡9  1‏
919 ‎‡a  deathcertificatebasedstudyofoccupationandmortalityfromreproductivecancersamongwomenin24usstates‏ ‎‡A  A death certificate-based study of occupation and mortality from reproductive cancers among women in 24 US states‏ ‎‡9  1‏
919 ‎‡a  retrospectivereviewofmedicalerrorsadjudicatedincourtbetween2002and2012inspain‏ ‎‡A  A retrospective review of medical errors adjudicated in court between 2002 and 2012 in Spain‏ ‎‡9  1‏
919 ‎‡a  actitudesdelostrabajadoresfrentealosprogramasdepromociondelasaludparalaprevenciondelcancerenellugardeltrabajo‏ ‎‡A  Actitudes de los trabajadores frente a los programas de promoción de la salud para la prevención del cáncer en el lugar del trabajo‏ ‎‡9  1‏
919 ‎‡a  aggressivenessfeaturesandoutcomesoftrueintervalcancerscomparisonbetweenscreendetectedandsymptomdetectedcancers‏ ‎‡A  Aggressiveness features and outcomes of true interval cancers: comparison between screen-detected and symptom-detected cancers.‏ ‎‡9  1‏
919 ‎‡a  analysisofbarriersandlegalethicalopportunitiesfordisclosureandapologyformedicalerrorsinspain‏ ‎‡A  Analysis of barriers and legal-ethical opportunities for disclosure and apology for medical errors in Spain‏ ‎‡9  1‏
919 ‎‡a  analysisofdrugrelatedproblemsinatertiaryuniversityhospitalinbarcelonaspain‏ ‎‡A  [Analysis of drug-related problems in a tertiary university hospital in Barcelona (Spain)]‏ ‎‡9  1‏
919 ‎‡a  anxietyanddepressioninwomenwithbreastcancersocialandclinicaldeterminantsandinfluenceofthesocialnetworkandsocialsupportdamacohort‏ ‎‡A  Anxiety and depression in women with breast cancer: Social and clinical determinants and influence of the social network and social support (DAMA cohort)‏ ‎‡9  1‏
919 ‎‡a  assessmentoffeasibilityofworkplacehealthpromotion‏ ‎‡A  Assessment of Feasibility of Workplace Health Promotion‏ ‎‡9  1‏
919 ‎‡a  associationbetweensocioeconomicdeprivationandcolorectalcancerscreeningoutcomeslowuptakeratesamongthemostandleastdeprivedpeople‏ ‎‡A  Association between socioeconomic deprivation and colorectal cancer screening outcomes: Low uptake rates among the most and least deprived people.‏ ‎‡9  1‏
919 ‎‡a  associationbetweenvisualimpairmentandpatientreportedvisualdisabilityatdifferentstagesofcataractsurgery‏ ‎‡A  Association between visual impairment and patient-reported visual disability at different stages of cataract surgery‏ ‎‡9  1‏
919 ‎‡a  associationofdiabetesanddiabetestreatmentwithincidenceofbreastcancer‏ ‎‡A  Association of diabetes and diabetes treatment with incidence of breast cancer‏ ‎‡9  1‏
919 ‎‡a  biomarkersexpressioninbenignbreastdiseasesandriskofsubsequentbreastcanceracasecontrolstudy‏ ‎‡A  Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case-control study‏ ‎‡9  1‏
919 ‎‡a  breastcancerriskafterdiagnosisbyscreeningmammographyofnonproliferativeorproliferativebenignbreastdiseaseastudyfromapopulationbasedscreeningprogram‏ ‎‡A  Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program.‏ ‎‡9  1‏
919 ‎‡a  budgetimpactanalysisofswitchingtodigitalmammographyinapopulationbasedbreastcancerscreeningprogramadiscreteeventsimulationmodel‏ ‎‡A  Budget impact analysis of switching to digital mammography in a population-based breast cancer screening program: a discrete event simulation model‏ ‎‡9  1‏
919 ‎‡a  canthegailmodelincreasethepredictivevalueofapositivemammograminaeuropeanpopulationscreeningsettingresultsfromaspanishcohort‏ ‎‡A  Can the Gail model increase the predictive value of a positive mammogram in a European population screening setting? Results from a Spanish cohort‏ ‎‡9  1‏
919 ‎‡a  cancermortalityinworkersexposedtoorganochlorinecompoundsinthepulpandpaperindustryaninternationalcollaborativestudy‏ ‎‡A  Cancer mortality in workers exposed to organochlorine compounds in the pulp and paper industry: an international collaborative study‏ ‎‡9  1‏
919 ‎‡a  cancerriskintherubberindustryareviewoftherecentepidemiologicalevidence‏ ‎‡A  Cancer risk in the rubber industry: a review of the recent epidemiological evidence‏ ‎‡9  1‏
919 ‎‡a  changesinconcentrationsoforganochloridecompoundsinwomenfromflixtarragona‏ ‎‡A  [Changes in concentrations of organochloride compounds in women from Flix, Tarragona [Spain]].‏ ‎‡9  1‏
919 ‎‡a  changesinfitvaluesbelowthethresholdofpositivityandshorttermriskofadvancedcolorectalneoplasiaresultsfromapopulationbasedcancerscreeningprogram‏ ‎‡A  Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program‏ ‎‡9  1‏
919 ‎‡a  clinicalandhistologiccharacteristicsofbreastcancersinwomenwithpreviouspathologicdiagnosisofbenignbreastdiseaseinspain‏ ‎‡A  Clinical and histologic characteristics of breast cancers in women with previous pathologic diagnosis of benign breast disease in Spain.‏ ‎‡9  1‏
919 ‎‡a  clinicalandradiologicalfeaturesofbreasttumorsaccordingtohistoryoffalsepositiveresultsinmammographyscreening‏ ‎‡A  Clinical and radiological features of breast tumors according to history of false-positive results in mammography screening‏ ‎‡9  1‏
919 ‎‡a  coffeeconsumptionandbladdercancerinnonsmokersapooledanalysisofcasecontrolstudiesineuropeancountries‏ ‎‡A  Coffee consumption and bladder cancer in nonsmokers: a pooled analysis of case-control studies in European countries.‏ ‎‡9  1‏
919 ‎‡a  correctiontohealthcareservicesuseamonglongtermbreastcancersurvivorsasystematicreview‏ ‎‡A  Correction to: Health care services use among long-term breast cancer survivors: a systematic review‏ ‎‡9  1‏
919 ‎‡a  costattributabletonosocomialbacteremiaanalysisaccordingtomicroorganismandantimicrobialsensitivityinauniversityhospitalinbarcelona‏ ‎‡A  Cost Attributable to Nosocomial Bacteremia. Analysis According to Microorganism and Antimicrobial Sensitivity in a University Hospital in Barcelona.‏ ‎‡9  1‏
919 ‎‡a  costeffectivenessofearlydetectionofbreastcancerincataloniaspain‏ ‎‡A  Cost-effectiveness of early detection of breast cancer in Catalonia (Spain).‏ ‎‡9  1‏
919 ‎‡a  costesasociadosalasbacteriemiasnosocomialesen1hospitaluniversitario‏ ‎‡A  Costes asociados a las bacteriemias nosocomiales en un hospital universitario‏ ‎‡9  1‏
919 ‎‡a  crossnationalcomparisonofscreeningmammographyaccuracymeasuresinusnorwayandspain‏ ‎‡A  Cross-national comparison of screening mammography accuracy measures in U.S., Norway, and Spain.‏ ‎‡9  1‏
919 ‎‡a  detectionmethodspredictdifferencesinbiologyandsurvivalinbreastcancerpatients‏ ‎‡A  Detection methods predict differences in biology and survival in breast cancer patients.‏ ‎‡9  1‏
919 ‎‡a  doesdigitalmammographysupposeanadvanceinearlydiagnosistrendsinperformanceindicators6yearsafterdigitalization‏ ‎‡A  Does digital mammography suppose an advance in early diagnosis? Trends in performance indicators 6 years after digitalization‏ ‎‡9  1‏
919 ‎‡a  economicimpactofnosocomialbacteraemiaacomparisonof3calculationmethods‏ ‎‡A  Economic impact of nosocomial bacteraemia. A comparison of three calculation methods‏ ‎‡9  1‏
919 ‎‡a  effectoffalsepositivesandwomenscharacteristicsonlongtermadherencetobreastcancerscreening‏ ‎‡A  Effect of false-positives and women's characteristics on long-term adherence to breast cancer screening‏ ‎‡9  1‏
919 ‎‡a  mammographicandclinicalcharacteristicsofdifferentphenotypesofscreendetectedandintervalbreastcancersinanationwidescreeningprogram‏ ‎‡A  Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.‏ ‎‡9  1‏
919 ‎‡a  levelsofhexachlorobenzeneandotherorganochlorinecompoundsincordbloodexposureacrossplacenta‏ ‎‡A  Levels of hexachlorobenzene and other organochlorine compounds in cord blood: exposure across placenta.‏ ‎‡9  1‏
919 ‎‡a  informationtopatientthroughaninformedconsent‏ ‎‡A  Information to patient through an informed consent‏ ‎‡9  1‏
919 ‎‡a  influenceofsocialdeterminantslifestyleemotionalwellbeingandtheuseofunconventionaltherapiesinbreastcancerprogressioninacohortofwomeninbarcelonaprotocolforthedamacohort‏ ‎‡A  Influence of Social Determinants, Lifestyle, Emotional Well-Being and the Use of Unconventional Therapies in Breast Cancer Progression in a Cohort of Women in Barcelona: Protocol for the DAMA Cohort.‏ ‎‡9  1‏
919 ‎‡a  incrementalcostofnosocomialbacteremiaaccordingtothefocusofinfectionandantibioticsensitivityofthecausativemicroorganisminauniversityhospital‏ ‎‡A  Incremental cost of nosocomial bacteremia according to the focus of infection and antibiotic sensitivity of the causative microorganism in a university hospital.‏ ‎‡9  1‏
919 ‎‡a  impactofthedistinctdiagnosticcriteriausedinpopulationbasedstudiesonestimationoftheprevalenceofkneeosteoarthritis‏ ‎‡A  [Impact of the distinct diagnostic criteria used in population-based studies on estimation of the prevalence of knee osteoarthritis]‏ ‎‡9  1‏
919 ‎‡a  effectofinformationaboutthebenefitsandharmsofmammographyonwomensdecisionmakingtheinformarandomisedcontrolledtrial‏ ‎‡A  Effect of information about the benefits and harms of mammography on women's decision making: The InforMa randomised controlled trial‏ ‎‡9  1‏
919 ‎‡a  effectofparticipationonthecumulativeriskoffalsepositiverecallinabreastcancerscreeningprogramme‏ ‎‡A  Effect of participation on the cumulative risk of false-positive recall in a breast cancer screening programme.‏ ‎‡9  1‏
919 ‎‡a  effectivenessandsafetyofcolistinforthetreatmentofmultidrugresistantpseudomonasaeruginosainfections‏ ‎‡A  Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections.‏ ‎‡9  1‏
919 ‎‡a  11yeardescriptiveanalysisofclosedcourtverdictsonmedicalerrorsinspainandmassachusetts‏ ‎‡A  Eleven-year descriptive analysis of closed court verdicts on medical errors in Spain and Massachusetts.‏ ‎‡9  1‏
919 ‎‡a  evaluationofhandhygieneadherenceinatertiaryhospital‏ ‎‡A  Evaluation of hand hygiene adherence in a tertiary hospital‏ ‎‡9  1‏
919 ‎‡a  evaluationoftheintervalcancerrateanditsdeterminantsonthegironahealthregionsearlybreastcancerdetectionprogram‏ ‎‡A  Evaluation of the interval cancer rate and its determinants on the Girona Health Region's early breast cancer detection program‏ ‎‡9  1‏
919 ‎‡a  excretionofhexachlorobenzeneandmetabolitesinfecesinahighlyexposedhumanpopulation‏ ‎‡A  Excretion of hexachlorobenzene and metabolites in feces in a highly exposed human population‏ ‎‡9  1‏
919 ‎‡a  exploringtheroleofbreastdensityoncancerprognosisamongwomenattendingpopulationbasedscreeningprogrammes‏ ‎‡A  Exploring the Role of Breast Density on Cancer Prognosis among Women Attending Population-Based Screening Programmes‏ ‎‡9  1‏
919 ‎‡a  exposicionacontaminantesatmosfericosduranteelembarazoydesarrolloprenatalyneonatalprotocolodeinvestigacionenelproyectoinma‏ ‎‡A  Exposición a contaminantes atmosféricos durante el embarazo y desarrollo prenatal y neonatal: protocolo de investigación en el proyecto INMA‏ ‎‡9  1‏
919 ‎‡a  exposicionacontaminantesatmosfericosduranteelembarazoydesarrolloprenatalyneonatalprotocolodeinvestigacionenelproyectoinmainfanciaymedioambiente‏ ‎‡A  Exposición a contaminantes atmosféricos durante el embarazo y desarrollo prenatal y neonatal: protocolo de investigación en el proyecto INMA (Infancia y Medio Ambiente)‏ ‎‡9  1‏
919 ‎‡a  exposuretoasbestosandlungandpleuralcancermortalityamongpulpandpaperindustryworkers‏ ‎‡A  Exposure to asbestos and lung and pleural cancer mortality among pulp and paper industry workers‏ ‎‡9  1‏
919 ‎‡a  externalvalidationofthepredicttoolinspanishwomenwithbreastcancerparticipatinginpopulationbasedscreeningprogrammes‏ ‎‡A  External validation of the PREDICT tool in Spanish women with breast cancer participating in population-based screening programmes‏ ‎‡9  1‏
919 ‎‡a  factorsthatinfluencetreatmentdelayforpatientswithbreastcancer‏ ‎‡A  Factors that Influence Treatment Delay for Patients with Breast Cancer‏ ‎‡9  1‏
919 ‎‡a  focusonhepatocellularcarcinoma‏ ‎‡A  Focus on hepatocellular carcinoma.‏ ‎‡9  1‏
919 ‎‡a  genderrelateddifferencesinclinicalandpathologicalcharacteristicsandtherapyofbladdercancer‏ ‎‡A  Gender-related differences in clinical and pathological characteristics and therapy of bladder cancer.‏ ‎‡9  1‏
919 ‎‡a  geneexpressionprofilingintrueintervalbreastcancerrevealsoveractivationofthemtorsignalingpathway‏ ‎‡A  Gene expression profiling in true interval breast cancer reveals overactivation of the mTOR signaling pathway‏ ‎‡9  1‏
919 ‎‡a  healthcareservicesuseamonglongtermbreastcancersurvivorsasystematicreview‏ ‎‡A  Health care services use among long-term breast cancer survivors: a systematic review‏ ‎‡9  1‏
919 ‎‡a  healtheffectsofchronichighexposuretohexachlorobenzeneinageneralpopulationsample‏ ‎‡A  Health effects of chronic high exposure to hexachlorobenzene in a general population sample‏ ‎‡9  1‏
919 ‎‡a  healthpromotiontrialsatworksitesandriskfactorsforcancer‏ ‎‡A  Health promotion trials at worksites and risk factors for cancer.‏ ‎‡9  1‏
919 ‎‡a  impactofcomorbidityonsurvivalbytumourlocationbreastcolorectalandlungcancer2000‏ ‎‡A  Impact of comorbidity on survival by tumour location: Breast, colorectal and lung cancer (2000-2014).‏ ‎‡9  1‏
919 ‎‡a  impactofadjuvantchemotherapyonthesurvivalofpatientswithbreastcancerdiagnosedbyscreening‏ ‎‡A  Impact of adjuvant chemotherapy on the survival of patients with breast cancer diagnosed by screening‏ ‎‡9  1‏
919 ‎‡a  variabilityofbreastsurgeryinwomenparticipatinginbreastcancerscreeningprograms‏ ‎‡A  Variability of breast surgery in women participating in breast cancer screening programs‏ ‎‡9  1‏
919 ‎‡a  useofrealworlddatatostudyhealthservicesutilisationandcomorbiditiesinlongtermbreastcancersurvivorsthesurbcanstudystudyprotocolforalongitudinalpopulationbasedcohortstudy‏ ‎‡A  Use of real-world data to study health services utilisation and comorbidities in long-term breast cancer survivors (the SURBCAN study): study protocol for a longitudinal population-based cohort study‏ ‎‡9  1‏
919 ‎‡a  trendsinhormonetherapyusebeforeandafterpublicationofthewomenshealthinitiativetrial10yearsoffollowup‏ ‎‡A  Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10 years of follow-up.‏ ‎‡9  1‏
919 ‎‡a  trendsindetectionofinvasivecancerandductalcarcinomainsituatbiennialscreeningmammographyinspainaretrospectivecohortstudy‏ ‎‡A  Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study‏ ‎‡9  1‏
919 ‎‡a  environmentandchildhoodresearchnetworkinmanetworkstudyprotocol‏ ‎‡A  The Environment and Childhood Research Network ("INMA" network): study protocol‏ ‎‡9  1‏
919 ‎‡a  environmentandchildhoodresearchnetwork‏ ‎‡A  [The Environment and Childhood Research Network‏ ‎‡9  1‏
919 ‎‡a  effectofsmokingonprostatecancersurvivalacohortanalysisinbarcelona‏ ‎‡A  The effect of smoking on prostate cancer survival: a cohort analysis in Barcelona‏ ‎‡9  1‏
919 ‎‡a  effectofinformationaboutthebenefitsandharmsofmammographyonwomensdecisionmakingstudyprotocolforarandomizedcontrolledtrial‏ ‎‡A  The effect of information about the benefits and harms of mammography on women's decision-making: study protocol for a randomized controlled trial‏ ‎‡9  1‏
919 ‎‡a  survivalanddiseasefreesurvivalbybreastdensityandphenotypeinintervalbreastcancers‏ ‎‡A  Survival and Disease-Free Survival by Breast Density and Phenotype in Interval Breast Cancers‏ ‎‡9  1‏
919 ‎‡a  socialcontextforworkplacehealthpromotionfeasibilityconsiderationsincostaricafinlandgermanyspainandsweden‏ ‎‡A  Social context for workplace health promotion: feasibility considerations in Costa Rica, Finland, Germany, Spain and Sweden‏ ‎‡9  1‏
919 ‎‡a  socialandclinicaldeterminantsoftheuseofhealthservicesinwomenwithbreastcancercohortdama‏ ‎‡A  [Social and clinical determinants of the use of health services in women with breast cancer (Cohort DAMA)]‏ ‎‡9  1‏
919 ‎‡a  smokingandbladdercancerinspaineffectsoftobaccotypetimingenvironmentaltobaccosmokeandgender‏ ‎‡A  Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender‏ ‎‡9  1‏
919 ‎‡a  17yearsoverviewofbreastcancerinsideandoutsidescreeningindenmark‏ ‎‡A  Seventeen-years overview of breast cancer inside and outside screening in Denmark‏ ‎‡9  1‏
919 ‎‡a  serumorganochlorinesandurinaryporphyrinpatterninapopulationhighlyexposedtohexachlorobenzene‏ ‎‡A  Serum organochlorines and urinary porphyrin pattern in a population highly exposed to hexachlorobenzene‏ ‎‡9  1‏
919 ‎‡a  serumconcentrationsofhexachlorobenzeneinfamilymembersofworkersinanelectrochemicalfactory‏ ‎‡A  Serum concentrations of hexachlorobenzene in family members of workers in an electrochemical factory.‏ ‎‡9  1‏
919 ‎‡a  seroprevalenceofbartonellasppinfectioninhivpatientsincataloniaspain‏ ‎‡A  Seroprevalence of Bartonella spp. infection in HIV patients in Catalonia, Spain.‏ ‎‡9  1‏
919 ‎‡a  riskofhospitalreadmissionandassociatedfactorsafterapositivesampleforamultidrugresistantmicroorganism‏ ‎‡A  Risk of hospital readmission and associated factors after a positive sample for a multidrug-resistant microorganism‏ ‎‡9  1‏
919 ‎‡a  riskofbreastcancerinwomenwithfalsepositiveresultsaccordingtomammographicfeatures‏ ‎‡A  Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features.‏ ‎‡9  1‏
919 ‎‡a  riskfactorsformultidrugresistantpseudomonasaeruginosaacquisitionimpactofantibioticuseinadoublecasecontrolstudy‏ ‎‡A  Risk factors for multidrug-resistant Pseudomonas aeruginosa acquisition. Impact of antibiotic use in a double case–control study‏ ‎‡9  1‏
919 ‎‡a  riskexcessofsofttissuesarcomaandthyroidcancerinacommunityexposedtoairborneorganochlorinatedcompoundmixtureswithahighhexachlorobenzenecontent‏ ‎‡A  Risk excess of soft-tissue sarcoma and thyroid cancer in a community exposed to airborne organochlorinated compound mixtures with a high hexachlorobenzene content.‏ ‎‡9  1‏
919 ‎‡a  resultsofacervicalcancerscreeningprogrammefromanareaofbarcelonaspainwithalargeimmigrantpopulation‏ ‎‡A  Results of a cervical cancer screening programme from an area of Barcelona (Spain) with a large immigrant population.‏ ‎‡9  1‏
919 ‎‡a  resultsofacervicalcancerscreeningprogrammefromanareaofbarcelona‏ ‎‡A  Results of a cervical cancer screening programme from an area of Barcelona‏ ‎‡9  1‏
919 ‎‡a  relationshipofcolonoscopydetectedserratedpolypswithsynchronousadvancedneoplasiainaverageriskindividuals‏ ‎‡A  Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals‏ ‎‡9  1‏
919 ‎‡a  reflectionsonpracticesforearlycancerdiagnosisinspain‏ ‎‡A  [Reflections on practices for early cancer diagnosis in Spain]‏ ‎‡9  1‏
919 ‎‡a  reductioninfalsepositiveresultsafterintroductionofdigitalmammographyanalysisfrom4populationbasedbreastcancerscreeningprogramsinspain‏ ‎‡A  Reduction in false-positive results after introduction of digital mammography: analysis from four population-based breast cancer screening programs in Spain.‏ ‎‡9  1‏
919 ‎‡a  readmissionsandcomplicationsinbreastductalcarcinomainsituaretrospectivestudycomparingscreenandnonscreendetectedpatients‏ ‎‡A  Readmissions and complications in breast ductal carcinoma in situ: A retrospective study comparing screen- and non-screen-detected patients‏ ‎‡9  1‏
919 ‎‡a  prevalenceofpersistentpainafterbreastcancertreatmentbydetectionmodeamongparticipantsinpopulationbasedscreeningprograms‏ ‎‡A  Prevalence of persistent pain after breast cancer treatment by detection mode among participants in population-based screening programs‏ ‎‡9  1‏
919 ‎‡a  prevalenceoffecalincontinenceanditsrelationshipwithbowelhabitinpatientsattendedinprimarycare‏ ‎‡A  Prevalence of fecal incontinence and its relationship with bowel habit in patients attended in primary care‏ ‎‡9  1‏
919 ‎‡a  prevalenceoffaecalincontinenceandanalysisofitsimpactonqualityoflifeandmentalhealth‏ ‎‡A  Prevalence of faecal incontinence and analysis of its impact on quality of life and mental health‏ ‎‡9  1‏
919 ‎‡a  practicasdecribadodecanceryestilosdevidaasociadosenlapoblaciondecontrolesdelestudioespanolmulticasocontrol1200spain‏ ‎‡A  Prácticas de cribado de cáncer y estilos de vida asociados en la población de controles del estudio español multi-caso control (MCC-Spain)‏ ‎‡9  1‏
919 ‎‡a  practicasdecribadodecanceryestilosdevidaasociadosenlapoblaciondecontrolesdelestudioespanolmulticasocontrol‏ ‎‡A  Prácticas de cribado de cáncer y estilos de vida asociados en la población de controles del estudio español multi-caso control‏ ‎‡9  1‏
919 ‎‡a  polychlorinatedbiphenylspcbsandneurologicaldevelopmentinchildrenasystematicreview‏ ‎‡A  Polychlorinated biphenyls (PCBs) and neurological development in children: a systematic review‏ ‎‡9  1‏
919 ‎‡a  phenotypiccharacterizationandriskfactorsforintervalbreastcancersinapopulationbasedbreastcancerscreeningprograminbarcelonaspain‏ ‎‡A  Phenotypic characterization and risk factors for interval breast cancers in a population-based breast cancer screening program in Barcelona, Spain‏ ‎‡9  1‏
919 ‎‡a  pesticidesandcongenitalmalformationshowmanystudieswillittaketoreachaconclusion‏ ‎‡A  Pesticides and congenital malformations--how many studies will it take to reach a conclusion?‏ ‎‡9  1‏
919 ‎‡a  organochlorinecompoundsandconcentrationsofthyroidstimulatinghormoneinnewborns‏ ‎‡A  Organochlorine compounds and concentrations of thyroid stimulating hormone in newborns.‏ ‎‡9  1‏
919 ‎‡a  occupationandbladdercancerinahospitalbasedcasecontrolstudyinspain‏ ‎‡A  Occupation and bladder cancer in a hospital-based case-control study in Spain.‏ ‎‡9  1‏
919 ‎‡a  metabolismofhexachlorobenzeneinhumansassociationbetweenserumlevelsandurinarymetabolitesinahighlyexposedpopulation‏ ‎‡A  Metabolism of hexachlorobenzene in humans: association between serum levels and urinary metabolites in a highly exposed population‏ ‎‡9  1‏
919 ‎‡a  medidadecontaminantesdelaguayusosdelaguaduranteelembarazoen1estudiodecohortesenespana‏ ‎‡A  Medida de contaminantes del agua y usos del agua durante el embarazo en un estudio de cohortes en España‏ ‎‡9  1‏
919 ‎‡a  mammographicbreastdensityhowitaffectsperformanceindicatorsinscreeningprogrammes‏ ‎‡A  Mammographic breast density: How it affects performance indicators in screening programmes?‏ ‎‡9  1‏
943 ‎‡a  201x‏ ‎‡A  2014‏ ‎‡9  1‏
946 ‎‡a  a‏ ‎‡9  1‏
996 ‎‡2  DE633|pe30070758‏
996 ‎‡2  DNB|1077219237‏
996 ‎‡2  NTA|306863235‏
996 ‎‡2  BNE|XX841415‏
996 ‎‡2  NUKAT|n 2015136385‏
996 ‎‡2  BNE|XX6028951‏
996 ‎‡2  NUKAT|n 02047691‏
996 ‎‡2  LC|no 96027396‏
996 ‎‡2  BNC|981058512358806706‏
996 ‎‡2  PLWABN|9810642720805606‏
996 ‎‡2  NUKAT|n 2020217343‏
996 ‎‡2  ISNI|0000000056259514‏
996 ‎‡2  J9U|987007439058105171‏
996 ‎‡2  BNC|981058522982506706‏
996 ‎‡2  ISNI|0000000069382503‏
996 ‎‡2  SUDOC|189269707‏
996 ‎‡2  SUDOC|031462464‏
996 ‎‡2  DNB|1157301908‏
996 ‎‡2  DNB|1061265129‏
996 ‎‡2  NUKAT|n 2021126740‏
996 ‎‡2  CAOONL|ncf10406508‏
996 ‎‡2  RERO|A025817015‏
996 ‎‡2  LIH|LNB:CN,G;=1A‏
996 ‎‡2  BNCHL|10000000000000000250521‏
996 ‎‡2  SUDOC|229635172‏
996 ‎‡2  DNB|1056170662‏
996 ‎‡2  ISNI|0000000059220228‏
996 ‎‡2  BNE|XX956766‏
996 ‎‡2  NTA|395011361‏
996 ‎‡2  BNF|16059755‏
996 ‎‡2  BNE|XX1477658‏
996 ‎‡2  NUKAT|n 97020625‏
996 ‎‡2  DNB|1173654100‏
996 ‎‡2  BNF|13092875‏
996 ‎‡2  ISNI|0000000061337695‏
996 ‎‡2  BNC|981061092262506706‏
996 ‎‡2  SUDOC|032023405‏
996 ‎‡2  BNC|981058516343806706‏
996 ‎‡2  NTA|133289982‏
996 ‎‡2  LC|no2023122958‏
996 ‎‡2  BNE|XX5414987‏
996 ‎‡2  RERO|A018545428‏
996 ‎‡2  NYNYRILM|203145‏
996 ‎‡2  ISNI|0000000110224911‏
996 ‎‡2  LC|n 95120429‏
996 ‎‡2  LC|n 2009013106‏
996 ‎‡2  ISNI|0000000060871482‏
996 ‎‡2  SUDOC|271440015‏
996 ‎‡2  ISNI|0000000077924835‏
996 ‎‡2  BNE|XX975710‏
996 ‎‡2  BNF|12267382‏
996 ‎‡2  LC|n 84211989‏
996 ‎‡2  DNB|1031655999‏
996 ‎‡2  DE633|pe30027522‏
996 ‎‡2  NUKAT|n 2004033515‏
996 ‎‡2  ISNI|0000000046290956‏
996 ‎‡2  SUDOC|031652212‏
996 ‎‡2  SUDOC|035110449‏
996 ‎‡2  BNE|XX1097633‏
996 ‎‡2  BAV|495_141807‏
996 ‎‡2  NUKAT|n 2020032639‏
996 ‎‡2  SUDOC|243248032‏
996 ‎‡2  RERO|A026076594‏
996 ‎‡2  DNB|1140854674‏
996 ‎‡2  LC|nb2011029562‏
996 ‎‡2  BNF|12282701‏
996 ‎‡2  BNF|14134575‏
996 ‎‡2  DNB|1158121598‏
996 ‎‡2  BNC|981058610204406706‏
996 ‎‡2  BNE|XX6081899‏
996 ‎‡2  BNE|XX4816542‏
996 ‎‡2  LC|nr 90017613‏
996 ‎‡2  BNC|981058517632106706‏
996 ‎‡2  NSK|000754736‏
996 ‎‡2  BNF|14836480‏
996 ‎‡2  BNE|XX992449‏
996 ‎‡2  NTA|390688142‏
996 ‎‡2  LC|no2020081312‏
996 ‎‡2  NKC|jcu2012685529‏
996 ‎‡2  RERO|A006490294‏
996 ‎‡2  BNC|981058529166306706‏
996 ‎‡2  BNC|981058595892606706‏
996 ‎‡2  BNC|981058520694106706‏
996 ‎‡2  BNE|XX1094974‏
996 ‎‡2  LC|no2021119938‏
996 ‎‡2  ISNI|0000000512548193‏
996 ‎‡2  BNCHL|10000000000000000811314‏
996 ‎‡2  BNC|981058517643106706‏
996 ‎‡2  NYNYRILM|68461‏
996 ‎‡2  NTA|069312257‏
996 ‎‡2  LC|no2003063701‏
996 ‎‡2  LIH|LNB:BW_i_D;=B_c_‏
996 ‎‡2  BNCHL|10000000000000000102508‏
996 ‎‡2  NUKAT|n 00093722‏
996 ‎‡2  BAV|495_149579‏
996 ‎‡2  BNE|XX4827922‏
996 ‎‡2  PTBNP|1008729‏
996 ‎‡2  LC|no2015162144‏
996 ‎‡2  NUKAT|n 2020026774‏
996 ‎‡2  BIBSYS|90387836‏
996 ‎‡2  DNB|1286269989‏
996 ‎‡2  SUDOC|149726953‏
996 ‎‡2  LC|no2010057222‏
996 ‎‡2  BIBSYS|90683380‏
996 ‎‡2  BNE|XX1393288‏
996 ‎‡2  LC|no2017070595‏
996 ‎‡2  SUDOC|069062080‏
996 ‎‡2  LC|n 87906115‏
996 ‎‡2  DNB|1222131501‏
996 ‎‡2  LC|n 2019069934‏
996 ‎‡2  LC|n 93101852‏
996 ‎‡2  BNC|981060934772506706‏
996 ‎‡2  LC|nr 97010698‏
996 ‎‡2  BNE|XX1191430‏
996 ‎‡2  ICCU|CFIV036663‏
996 ‎‡2  ISNI|0000000059485496‏
996 ‎‡2  BNC|981058516938806706‏
996 ‎‡2  RERO|A003779520‏
996 ‎‡2  PLWABN|9810587171605606‏
996 ‎‡2  BNC|981058612886406706‏
996 ‎‡2  LC|no2001021062‏
996 ‎‡2  SUDOC|267829493‏
996 ‎‡2  BNC|981058508986906706‏
996 ‎‡2  ISNI|0000000059596284‏
996 ‎‡2  NTA|111199409‏
996 ‎‡2  J9U|987007408547605171‏
996 ‎‡2  ISNI|0000000356600198‏
996 ‎‡2  NUKAT|n 2010175448‏
996 ‎‡2  NUKAT|n 2010055072‏
996 ‎‡2  SUDOC|196388198‏
996 ‎‡2  ISNI|0000000071734678‏
996 ‎‡2  BNC|981058508987206706‏
996 ‎‡2  BNC|981058610651506706‏
996 ‎‡2  SZ|1077219237‏
996 ‎‡2  NKC|jx20100720012‏
996 ‎‡2  NTA|39068810X‏
996 ‎‡2  ISNI|0000000039059035‏
996 ‎‡2  BNC|981058509582306706‏
996 ‎‡2  BNF|17774769‏
996 ‎‡2  J9U|987007429656005171‏
996 ‎‡2  BNF|18097011‏
996 ‎‡2  ISNI|0000000410056446‏
996 ‎‡2  SUDOC|230100775‏
996 ‎‡2  ISNI|0000000076043470‏
996 ‎‡2  BNE|XX1052147‏
996 ‎‡2  BAV|495_40907‏
996 ‎‡2  ISNI|0000000112521581‏
996 ‎‡2  DNB|1187380873‏
996 ‎‡2  BNE|XX934433‏
996 ‎‡2  LC|no2007141307‏
996 ‎‡2  ISNI|0000000496232964‏
996 ‎‡2  DNB|138364214‏
996 ‎‡2  PTBNP|582421‏
996 ‎‡2  LC|n 2017001700‏
996 ‎‡2  BNF|13167804‏
996 ‎‡2  BNF|15515389‏
996 ‎‡2  ISNI|0000000408773841‏
996 ‎‡2  LC|no 93022002‏
996 ‎‡2  SUDOC|183226968‏
996 ‎‡2  BNC|981058508994206706‏
996 ‎‡2  BAV|495_40906‏
996 ‎‡2  BNF|12313209‏
996 ‎‡2  DNB|1262902738‏
996 ‎‡2  NYNYRILM|153912‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏